Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
Submitted by
admin
on November 29, 2016 - 9:49am
Source:
TheStreet.com
News Tags:
Eli Lilly
Alzheimer's disease
solanezumab
AC Immune
Axovant
Biogen
Merck
Roche
Headline:
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
Do Not Allow Advertisers to Use My Personal information
